Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Since the study also ...
Sep 29, 2011
0
0
(Medical Xpress)—Researchers in the Life Sciences Institute at the University of Michigan have discovered how a particular type of virus hides and protects its genetic information from the immune system, a design that allows ...
Nov 7, 2012
0
0
In a poll conducted by The Guardian in August of 2021 about the number of deaths Australians would be willing to accept as restrictions eased, only 3% of respondents felt that 5,000 or more COVID-related deaths per year would ...
May 23, 2022
2
16
According to the World Health Organization, approximately 37 million people are living with HIV. Antiviral medications are used to control the disease and prevent its progression to AIDS. Although antivirals improve health ...
Mar 28, 2016
0
15
A phase II clinical trial demonstrated that a new type of treatment for genital herpes, an immunotherapy called GEN-003, may reduce the activity of the virus and the number of days with recurrent herpes. This effect of treatment, ...
Jun 20, 2016
0
8
Between 40,000 and 80,000 Austrians suffer from hepatitis C. With new infections the prompt and appropriate treatment is of great importance as this can prevent it developing into a chronic illness which in turn can progress ...
Jul 29, 2013
0
0
Norwegian researchers have previously demonstrated an association between diabetes and virus infection. New research shows that, among children with newly diagnosed type 1 diabetes (T1D), treatment with antiviral drugs could ...
Oct 4, 2023
0
20
Since COVID-19 first spread rapidly around the world in 2020, we have significantly more options to reduce the symptoms and severity of the virus. COVID-19 symptoms usually begin in the first five days after exposure and ...
Nov 28, 2023
0
1
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...
Dec 25, 2012
0
0
Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17.
Mar 9, 2022
0
18
